GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Evome Medical Technologies Inc (OTCPK:LNDZF) » Definitions » EBIT

Evome Medical Technologies (Evome Medical Technologies) EBIT : $-9.63 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Evome Medical Technologies EBIT?

Evome Medical Technologies's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $-10.84 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $-9.63 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Evome Medical Technologies's annualized ROC % for the quarter that ended in Dec. 2023 was -8.27%. Evome Medical Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -400.67%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Evome Medical Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -33.92%.


Evome Medical Technologies EBIT Historical Data

The historical data trend for Evome Medical Technologies's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evome Medical Technologies EBIT Chart

Evome Medical Technologies Annual Data
Trend Dec14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.77 -0.99 -3.22 -3.22 -9.62

Evome Medical Technologies Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Mar23 Jun23 Sep23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.01 -0.99 -0.50 2.69 -10.84

Competitive Comparison of Evome Medical Technologies's EBIT

For the Medical Devices subindustry, Evome Medical Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evome Medical Technologies's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Evome Medical Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Evome Medical Technologies's EV-to-EBIT falls into.



Evome Medical Technologies EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evome Medical Technologies  (OTCPK:LNDZF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Evome Medical Technologies's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-3.948 * ( 1 - -0.06% )/( (53.662 + 41.864)/ 2 )
=-3.9503688/47.763
=-8.27 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Evome Medical Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-43.344/( ( (11.332 + max(0.569, 0)) + (9.735 + max(-1.131, 0)) )/ 2 )
=-43.344/( ( 11.901 + 9.735 )/ 2 )
=-43.344/10.818
=-400.67 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(7.38 + 8.966 + 3.5527136788005E-15) - (7.33 + 0 + 8.447)
=0.569

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(5.817 + 7.635 + -0.0010000000000012) - (6.455 + 0 + 8.127)
=-1.131

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Evome Medical Technologies's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=-9.628/28.388
=-33.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evome Medical Technologies EBIT Related Terms

Thank you for viewing the detailed overview of Evome Medical Technologies's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Evome Medical Technologies (Evome Medical Technologies) Business Description

Traded in Other Exchanges
Address
6160 Innovation Way, Carlsbad, CA, USA, 92009
Evome Medical Technologies Inc is a medical device company. It is focused on human performance and rehabilitative solutions.

Evome Medical Technologies (Evome Medical Technologies) Headlines